These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32738970)

  • 1. Topical 'dual-soft' glucocorticoid receptor agonist for dermatology.
    Dack KN; Johnson PS; Henriksson K; Eirefelt S; Carnerup MA; Stahlhut M; Ollerstam AK
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127402. PubMed ID: 32738970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists.
    Sheppeck JE; Gilmore JL; Xiao HY; Dhar TG; Nirschl D; Doweyko AM; Sack JS; Corbett MJ; Malley MF; Gougoutas JZ; Mckay L; Cunningham MD; Habte SF; Dodd JH; Nadler SG; Somerville JE; Barrish JC
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5442-7. PubMed ID: 23953070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists.
    Yates CM; Brown PJ; Stewart EL; Patten C; Austin RJ; Holt JA; Maglich JM; Angell DC; Sasse RZ; Taylor SJ; Uings IJ; Trump RP
    J Med Chem; 2010 Jun; 53(11):4531-44. PubMed ID: 20469868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel steroidal agonists, partial agonists, and antagonists for the glucocorticoid receptor.
    Jin Z; Lin H; Srinivasan S; Nwachukwu JC; Bruno N; Griffin PR; Nettles KW; Kamenecka TM
    Bioorg Med Chem Lett; 2017 Jan; 27(2):347-353. PubMed ID: 27919657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators.
    Hemmerling M; Edman K; Lepistö M; Eriksson A; Ivanova S; Dahmén J; Rehwinkel H; Berger M; Hendrickx R; Dearman M; Jensen TJ; Wissler L; Hansson T
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5741-5748. PubMed ID: 27810243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs.
    Bäumer W; Rossbach K; Schmidt BH
    Vet Dermatol; 2017 Feb; 28(1):46-e11. PubMed ID: 27425245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEGRAs: a novel class of anti-inflammatory compounds.
    Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
    Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate.
    Berger M; May E; Rehwinkel H; Schäcke H; Neuhaus R; Rottmann A; Zollner TM; Jaroch S
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127298. PubMed ID: 32631518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a potent series of non-steroidal non α-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicity.
    Diallo H; Angell DC; Barnett HA; Biggadike K; Coe DM; Cooper TW; Craven A; Gray JR; House D; Jack TI; Keeling SP; Macdonald SJ; McLay IM; Oliver S; Taylor SJ; Uings IJ; Wellaway N
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1126-33. PubMed ID: 21257309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists.
    Gilmore JL; Sheppeck JE; Wang J; Dhar TG; Cavallaro C; Doweyko AM; Mckay L; Cunningham MD; Habte SF; Nadler SG; Dodd JH; Somerville JE; Barrish JC
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5448-51. PubMed ID: 23916594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment.
    Eirefelt S; Stahlhut M; Svitacheva N; Carnerup MA; Da Rosa JMC; Ewald DA; Marstrand TT; Krogh-Madsen M; Dünstl G; Dack KN; Ollerstam A; Norsgaard H
    Sci Rep; 2022 Jan; 12(1):1501. PubMed ID: 35087193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel selective glucocorticoid receptor agonists (SEGRAs) with a covalent warhead for long-lasting inhibition.
    Ryabtsova O; Joossens J; Van Der Veken P; Vanden Berghe W; Augustyns K; De Winter H
    Bioorg Med Chem Lett; 2016 Oct; 26(20):5032-5038. PubMed ID: 27612544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.
    Schäcke H; Zollner TM; Döcke WD; Rehwinkel H; Jaroch S; Skuballa W; Neuhaus R; May E; Zügel U; Asadullah K
    Br J Pharmacol; 2009 Oct; 158(4):1088-103. PubMed ID: 19422381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Functionalized indazoles as glucocorticoid receptor agonists.
    Bai M; Carr G; Deorazio RJ; Friedrich TD; Dobritsa S; Fitzpatrick K; Guzzo PR; Kitchen DB; Lynch MA; Peace D; Sajad M; Usyatinsky A; Wolf MA
    Bioorg Med Chem Lett; 2010 May; 20(10):3017-20. PubMed ID: 20427184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted phenyl as a steroid A-ring mimetic: providing agonist activity to a class of arylsulfonamide nonsteroidal glucocorticoid ligands.
    DiSalvo D; Kuzmich D; Bentzien J; Regan J; Kukulka A; Fadra-Khan T; Nelson R; Harcken C; Thomson D; Nabozny G
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6645-9. PubMed ID: 24239189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal glucocorticoid agonists: the discovery of aryl pyrazoles as A-ring mimetics.
    Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Minick DJ; Skone PA; Uings I; McLay IM; Macdonald SJ
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4737-45. PubMed ID: 17616395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses.
    Kubin ME; Hägg PM; Kokkonen N; Väyrynen JP; Haapasaari KM; Moilanen J; Kallioinen M; Hurskainen T; Tasanen K
    Eur J Dermatol; 2016; 26(1):21-7. PubMed ID: 26711698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads.
    Chirumamilla CS; Palagani A; Kamaraj B; Declerck K; Verbeek MWC; Oksana R; De Bosscher K; Bougarne N; Ruttens B; Gevaert K; Houtman R; De Vos WH; Joossens J; Van Der Veken P; Augustyns K; Van Ostade X; Bogaerts A; De Winter H; Vanden Berghe W
    Front Immunol; 2017; 8():1324. PubMed ID: 29163463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.